Expression of miR-152 in cervical cancer and its influence on cisplatin resistance
Conclusion: MiR-152 suppresses the proliferation, migration and infiltration of cervical cancer cells and reduces their resistanceto DDP chemotherapy by inhibiting the expressions of proteins in the ERBB3/Akt/c-myc and ERBB3/Akt/Snail pathways.Keywords: miR-152; cervical cancer; cisplatin; drug resistance.
Source: African Health Sciences - Category: African Health Authors: Jun Wu, Xiaoping Chi, Qian Yang, Jinxiao Li Source Type: research
More News: African Health | Cancer | Cancer & Oncology | Cervical Cancer | Chemotherapy | Genetics | Study